Palvella Therapeutics (PVLA) Stock Price & Financial Analysis
Palvella Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Palvella Therapeutics
What is the current stock price for PVLA?
As of the latest trading session, PVLA stock trades at $105.05. The 52-week range is $20.20–$151.18, with a day range of $103.61–$114.29.
What is the P/E ratio for PVLA?
The P/E ratio (Price-to-Earnings) for PVLA is shown in the Key Statistics section. This valuation metric helps compare Palvella Therapeutics, Inc. to industry peers.
Does PVLA pay dividends?
Palvella Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PVLA?
Based on 4 analysts, the consensus for PVLA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of PVLA?
Palvella Therapeutics's market capitalization is $1.18B, classifying it as a small-cap company. Palvella Therapeutics operates in the Healthcare sector within the Biotechnology industry.